Clindamycin Injection (Iv/Im) 300 mg/2 mL, 600 mg/4 mL Suppliers & Bulk Manufacturers

Clindamycin Injection is used to treat serious bacterial infections caused by susceptible bacteria, particularly anaerobic bacteria and certain gram-positive organisms. It is commonly prescribed for respiratory tract infections, skin and soft tissue infections, bone and joint infections, intra-abdominal infections, septicemia, and gynecological infections. The injectable form is typically used in hospital settings when oral therapy is not suitable or when rapid therapeutic action is required.

Clindamycin Injection contains the active pharmaceutical ingredient clindamycin phosphate, which is the injectable form of the antibiotic clindamycin. It belongs to the lincosamide class of antibiotics and works by inhibiting bacterial protein synthesis, thereby preventing the growth and multiplication of bacteria.

Clindamycin Injection is marketed under several trade names worldwide including Cleocin Injection, Dalacin C Injection, and other generic clindamycin injectable brands depending on the manufacturer and region.

One of the well-known brands, Cleocin Injection, was originally developed and marketed by Pfizer. Today, clindamycin injection is manufactured globally by several pharmaceutical companies including Teva Pharmaceutical Industries, Sandoz, and Viatris along with other generic manufacturers.

The generic name of Clindamycin Injection is clindamycin phosphate.

Common brand names of Clindamycin Injection include Cleocin Injection and Dalacin C Injection.

Clindamycin Injection is manufactured in several countries including the United States, India, China, and multiple European countries by different pharmaceutical manufacturers supplying both branded and generic injectable formulations for global markets.